ESPL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Similar results were obtained when paired clinical samples (n = 5), each pair derived from the same CML patient before (at diagnosis) and during IM therapy were comparatively monitored for c-MYB and ESPL1 transcript levels (Fig. 2).